Certara, Inc. (CERT) Stock Score, Valuation & Financial Research
Certara, Inc. is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 26/100.
Quick answer for CERT
Certara, Inc. currently has a Wall Street Score of 26/100. The stored market price is $8.13. Its financial score is 41/100. Its valuation score is 0/100. The latest WSS change is +0.2 points. These figures are a research snapshot, not a buy or sell recommendation.
What Certara, Inc. does
Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical biosimulation, strategic guidance for drug development and regulatory affairs, clinical pharmacology, model-based meta-analysis, specialized regulatory writing and medical communications, regulatory operations support, and market access consultation. Furthermore, Certara offers a robust suite of software platforms covering mechanistic and empirical PK/PD
CERT financial snapshot
- Wall Street Score:
- 26/100
- Current price:
- $8.13
- Market capitalization:
- $1.26B
- Revenue:
- $408.4M
- Net income:
- $-68.4M
- Free cash flow:
- $69.8M
- Cash:
- $184.1M
- Total debt:
- $291.8M
- EPS:
- -0.44
- Financial score:
- 41/100
- Valuation score:
- 0/100
- Revenue score:
- 10/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $69.8M, showing positive cash generation.
- The balance sheet shows $184.1M of cash versus $291.8M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.2 points: CERT increased 0.2 points because overall fundamentals improved.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 41/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-14.
How to research CERT
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.